Metabolism of Cancer Tissues: The Role of Different Pathways
Author Information
Author(s): G. H. Van Vals, R. P. Van Hoeven, L. Bosch, P. Emmelot
Primary Institution: The Netherknils Cancer Institute, Amsterdam
Hypothesis
The study investigates the contributions of the hexosemonophosphate oxidative pathway and the Embden-Meyerhof pathway in the metabolism of glucose in neoplastic tissues.
Conclusion
The study found that the HMP shunt contributes significantly to the metabolism of glucose in various tumor types, with varying contributions to lactate, fatty acids, and cholesterol production.
Supporting Evidence
- The study measured the incorporation of C14 from glucose into various metabolic products in tumor slices.
- It was found that the HMP shunt contributed significantly to the conversion of glucose to lactate, fatty acids, and cholesterol.
- The results indicated that the contribution of the HMP shunt varied widely among different tumor types.
Takeaway
This study looks at how cancer cells use sugar differently than normal cells, showing that they have a special way to break down sugar that helps them grow.
Methodology
The study involved incubating tumor slices with labeled glucose and measuring the incorporation of carbon into various metabolic products.
Limitations
The assumptions used for calculating the contributions of the metabolic pathways may be too simplistic and not fully accurate.
Participant Demographics
The study used tumor slices from mouse and rat tumors.
Want to read the original?
Access the complete publication on the publisher's website